While the role played by IgA in the regulation of gut bacterial homeostasis appears now clearer, in our perspective there are currently no optimalcommercial IgA antibody preparations for oral use to test for their ability to regulate gut microbiome dysbiosis associated with primary antibody deficiencies. This evidence concerns the gene CD79A and agammaglobulinemia.